Clinical Trial Update: Study on Neutropenia Induced by Adjuvant Paclitaxel/Carboplatin Chemotherapy in Patients With Epithelial Ovarian Cancer

View source ↗

Summary

Clinical trial update notes neutropenia observed in patients with epithelial ovarian cancer receiving adjuvant paclitaxel/carboplatin chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epithelial Ovarian Cancer
• Ovarian Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• PACLITAXEL (PACLITAXEL)

Snippet

Sponsor: Asan Medical Center | Conditions: Epithelial Ovarian Cancer | Status: UNKNOWN